GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial ...

In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...

Santa Monica-based prescription medication discount provider GoodRx Holdings Inc. wants its customers and other medication ...

The National Community Pharmacists Association has joined a class action lawsuit against GoodRx, as well as CVS Caremark, ...

We recently compiled a list of the 10 Best Affordable Stocks Under $5 to Buy Now. In this article, we are going to take a ...

Goodrx Holdings Inc (GDRX) stock saw a modest uptick, ending the day at $4.57 which represents a slight increase of $0.15 or 3.39% from the prior close of $4.42. The stock opened at $4.41 and touched ...

Healthcare leaders shared insights on various topics, including industry challenges, a new administration and growing their ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

On Wednesday, the Food & Drug Administration (FDA) banned red dye No. 3 from all food products in the United States due to potential cancer risk, but this raises an important ...

Rising drug prices remain a contentious issue in the US. Credit: Malte Mueller via Getty Images. At the 2025 JP Morgan Healthcare Conference, GoodRx’s recently appointed CEO Wendy Barnes highlighted ...

The development of drug treatments for obesity in adults has raised questions about treatment of childhood obesity. Image credit: PeopleImages.com – Yuri A The prevalence of obesity has increased ...

Leerink Partners analyst Michael Cherny has reiterated their neutral stance on TDOC stock, giving a Hold rating yesterday.Stay Ahead of the ...